Blood Collection Devices Market Dynamics, Industry Research, Demand Outlook to 2032

[250 Pages Report] The blood collection devices market is anticipated to grow at a CAGR of 6.3% and surpass US$ 11 billion by 2032, up from US$ 6 billion in 2021.

Competitive Landscape:

A few of the major players are Smiths Medical (US), Dickinson and Company (US), Terumo BCT (US), Retractable Technologies (US), Fresenius Kabi AG (Germany), Becton, Grifols S.A.(Spain), Terumo BCT (US), Haematonics (US), Greiner Holding (Austria), Quest Diagnostics (US), Nipro Medical Corporation (Japan), SARSTEDT AG & Co. (Germany), Macopharma (France), and Cardinal Health (US).

To increase their share, major corporations are pursuing a variety of organic and inorganic strategies such as collaborations, new product development, acquisitions, and regional expansion.

Market Dynamics:

The rising number of accidents and trauma cases, the emergence of liquid biopsy tests, and the demand for blood donations and blood components are some pivotal factors driving the demand for blood collection devices and propelling the market. A major factor shaping the demand for blood collection devices is the rising prevalence of infectious diseases such as hepatitis B (HBV), hepatitis C (HCV), human immunodeficiency virus (HIV), malaria, syphilis, and brucellosis.

A greater emphasis and adherence to health checkups and awareness of disease conditions via blood collection/blood drawing device ensued from burden of various chronic diseases, prevalence of lifestyle diseases around the globe, especially in emerging countries.

As blood tests are the primary mode of diagnosing these diseases, this will flourish the blood collection devices market growth and act as a significant contributor to the adoption of blood collection devices. The global outbreak of COVID-19 is expected to have a positive impact on the blood collection devices adoption trends since blood testing involves the testing of various blood samples, which aids in the diagnosis of infectious diseases such as COVID-19.

Testing is still an important step in combating the COVID-19 pandemic. As the number of COVID-19 cases grows worldwide, governments around the world are looking into the possibility of allowing private laboratories to ramp up blood testing and in turn booming the market. Taking into account all the aforesaid factors, the blood collection devices market is forecasted to reach US$ 8 Bn by 2026.

Key Segments Covered:

By Type:

  • Blood collection tubes
  • Needles & syringes
  • Blood bags
  • Blood collection systems or monitors
  • System type
  • Lancets
  • Others

By End User:

  • Hospitals, Ambulatory Surgical Centre & Nursing Homes
  • Blood Bank
  • Diagnostic & Pathology Laboratories
  • Others

By Method:

  • Manual Blood Collection
  • Automated Blood Collection

By Application:

  • Diagnostic
  • Therapeutic

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • Europe
  • Middle East & Africa

For More Information:

Comments are closed